Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-7.00	25.34	27.25
Graham Fair Price	109.53	4445.09	2121.41
PEG	-82.76	0.02	-0.10
Price/Book	37.27	1.26	0.92
Price/Cash Flow	54.36	7.04	-4.56
Prices/Earnings	-61.14	5.14	13.24
Price/Sales	13.43	1.29	1.14
Price/FCF	54.36	7.04	-4.56
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-12.04	0.20	0.22
Operating Margin	-8.15	0.07	0.07
ROA	291.35	0.01	< 0.005
ROE	0.02	0.06	253.28
ROIC	0.01	0.02	53.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.13	0.14	-6.80
Dividends QOQ	3.43	-0.93	-72.88
EBIT QOQ	1.78	0.24	-86.56
EPS QOQ	1.30	2.94	125.32
FCF QOQ	-4.11	1.99	-51.50
Revenue QOQ	0.26	0.35	32.74
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	195.66	128.16	-34.50
Days Sales Outstanding (DSO)	136.52	118.98	-12.85
Inventory Turnover	0.46	0.70	52.67
Debt/Capitalization	0.63	0.57	-9.41
Quick Ratio	0.52	0.59	14.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3395.76	3785.56	11.48
Cash	691.13	568.21	-17.78
Capex	-191.68	-95.41	50.23
Free Cash Flow	-684.11	678.21	-0.86
Revenue	2744.68	3702.75	34.91
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.10	1.12	2.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.02	12.36	-27.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating